intrahepatic cholangiocarcinoma
Human disease
Ratings
0
Nobody has rated this yet. Be the first!
Facility Type is Associated with Margin Status and Overall Survival of Patients with Resected Intrahepatic Cholangiocarcinoma
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma
Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities